Clinical Trials for Immunitas Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Immunitas Therapeutics

Clinical Trials (1)

NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2Active, not recruiting
67 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2026
12 conditions1 sponsor9 locations